Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Grand Pharmaceutical Group Limited ( (HK:0512) ) is now available.
Grand Pharmaceutical Group Limited issued a clarification regarding an operational mistake in the headline of its Bye-Laws document. The headline was incorrectly labeled as ‘Documents on Display’ instead of ‘Constitutional Documents’. The company has corrected this error by re-uploading the document with the correct headline, ensuring that the content of the Bye-Laws remains unchanged.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating within the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products, with a market presence highlighted by its listing on the Hong Kong Stock Exchange.
YTD Price Performance: 27.29%
Average Trading Volume: 5,721,817
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$21.44B
For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue